Effect of Risperidone with Ondansetron to Control the Negative and Depressive Symptoms in Schizophrenia
| Autor: | Aamira Hashmi, Muhammad Hashim Raza, Muhammad Tamour Danish, Hafiz Muhammad Mudassar Aslam, Sara Mubeen, Muhammad Imran |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
Risperidone Physics and Astronomy (miscellaneous) business.industry Depression lcsh:T medicine.disease Ondansetron lcsh:Technology Schizophrenia Management of Technology and Innovation medicine lcsh:Q Negative symptoms Psychiatry business lcsh:Science Engineering (miscellaneous) Depressive symptoms medicine.drug |
| Zdroj: | Advances in Science, Technology and Engineering Systems, Vol 3, Iss 3, Pp 100-103 (2018) |
| ISSN: | 2415-6698 |
| Popis: | To evaluate the effects of Ondansetron on the negative and depressive symptoms of patients with schizophrenia. A double-blind randomized control trial was conducted in 2016-17 in Lahore. 30 participants were included both in placebo and medicine group. The patients were assessed by using the Positive and Negative Syndrome Scale (PANSS) and Hamilton’s Rating Scale for Depression (HRSD) at baseline and at 12 weeks. The t-test and Chi square test were used to evaluate the data by using SPSS (version 21). The statistical significance was set at P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|